Date | Name | Shares | Transaction | Value |
Feb 24, 2025
| Chris A. Kosel VP-Corp Controller and CAO |
1,282
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $644.2 per share |
825,864.40
|
Jan 24, 2025
| John W. Norris Director |
530
| Other acquisition or disposition |
0.00
|
Jan 24, 2025
| John W. Norris Director |
146,835
| Other acquisition or disposition |
0.00
|
Jan 24, 2025
| John W. Norris Director |
213,168
| Other acquisition or disposition |
0.00
|
Dec 12, 2024
| Joseph F. Nassab EVP & Pres., Bldg Climate Sol. |
7,928
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
5,071,303.76
|
Dec 12, 2024
| Daniel M. Sessa EVP, Chief HR Officer |
31,634
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
20,235,320.78
|
Dec 12, 2024
| Gary S. Bedard EVP & Pres., Home Comfort Sol |
19,600
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
12,537,532.00
|
Dec 12, 2024
| Michael Quenzer EVP, Chief Financial Officer |
2,460
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
1,573,588.20
|
Dec 12, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
4,269
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
2,730,751.23
|
Dec 12, 2024
| Prakash Bedapudi EVP, Chief Technology Officer |
15,747
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $639.67 per share |
10,072,883.49
|
Nov 26, 2024
| Todd J. Teske Director |
7,911
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $675.52 per share |
5,344,038.72
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
14,170
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $577.67 per share |
8,185,583.90
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
11,884
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $577.67 per share |
6,865,030.28
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
9,060
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $570.34 per share |
5,167,280.40
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
6,785
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $571.24 per share |
3,875,863.40
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
5,341
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $572.36 per share |
3,056,974.76
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
4,812
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $573.38 per share |
2,759,104.56
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
4,712
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $574.06 per share |
2,704,970.72
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
4,668
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $575.95 per share |
2,688,534.60
|
Aug 20, 2024
| John D. Torres EVP, Chief Legal Officer & Sec |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|